Today, the New York State Office of Cannabis Management (OCM) announced the launch of a new Seed-to-Sale (STS) Tracking system to enhance regulatory oversight and transparency within the state’s cannabis industry.
This comprehensive system will require all licensees to use an electronic inventory system capable of integrating with the NY STS Tracking System (BioTrack). The implementation of this system ensures that cannabis is monitored from the planting stage through to final sale, securing the integrity of the supply chain for both adult-use and medical cannabis sectors.
As part of the initial launch, OCM will cover up to $250,000 in inventory tag purchases, a move that demonstrates the state’s commitment to supporting the industry’s cultivators, processors and microbusinesses compliance efforts as they get their STS Tracking Systems integrated into their business operations. These tags serve as unique identifiers for cannabis products, maintaining traceability from cultivation through processing, packaging, laboratory testing, and ultimately, sale. In addition to tracking products from production to retail, permitted laboratories are also required to submit cannabis product testing data to BioTrack, facilitating a seamless and integrated flow of information.
“The implementation of the Seed-to-Sale tracking system is a pivotal moment in the evolution of New York’s cannabis industry. This initiative upholds our commitment to transparency, accountability, and public trust,” said Felicia A.B. Reid, Acting Executive Director, New York State Office of Cannabis Management. “By ensuring traceability at every stage of the supply chain, we are not only bolstering compliance but also ensuring that both medical and adult-use consumers benefit from a regulated and secure market. The OCM is proud to take this important step toward shaping a sustainable, responsible, and equitable cannabis industry in New York.”
Mandated by Section 78 of the Cannabis Law, licensees are required to report their data to OCM via the BioTrack Application Programming Interface (API), which is now available for integration. By January 17, 2025, licensees must obtain a 3rd party inventory tracking system that will be capable of integrating with the NY-API. The Office will share additional information regarding the implementation logistics, and timeframe for integration as they become available. Please note, licensees will need to work with their software vendors to come into compliance with this data reporting requirement. This new system not only enhances OCM’s regulatory capabilities but also ensures that New York’s cannabis industry continues to operate with transparency and accountability, promoting public trust and compliance across the board.
For information on the NY STS Tracking System (BioTrack) visit Cannabis.ny.gov/seed-to-sale.
Recent Posts
- LISC CEO Michael T. Pugh Recognized Among 2024 Worthy 100 Leaders
- NY Lawmakers Celebrate Historic MENA Data Recognition Bill Signed By Hochul
- Sponsored Love: Leadership Skills Training Courses: Invest In Your Future Today
- Senator Hoylman-Sigal Calls On Independent Schools To Adopt NYC Public School Calendar
- Mayor Adams Celebrates 65 Million NYC Visitors In 2024, Second-Highest Ever
- Mayor’s Public Engagement Unit Expands Access To Resources Across NYC In 2024
- NYC Health + Hospitals Honors 35 Nurses And Six Hospitals At Awards Ceremony
- Harlem Rep. Espaillat Urges President Biden To Commute 40 Federal Death Row Inmates
- Zeta Charter Schools Celebrate New Stage With Ribbon Cutting And Performances
- Strategies For Revitalizing Your Business Post-Bankruptcy
- Sponsored Love: Aren’t The Spider Hoodies From Our Collection Best Ways To Be Effortlessly Stylish?
- The Wider Applications Of AI Image Generators In Everyday Lives
- Sponsored Love: 5 Hacks To Find Affordable Car Insurance In New Orleans
- Key Features To Look For When Choosing A Workspace For Your Business
- Manhattan BP Levine Announces Bold Plan For Universal Childcare From Harlem To Hollis
Become a Harlem Insider!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact